Arena Bioworks: Changing the Incentive Model for Biomedical Research

Last week, Steve Pagliuca was flying to Milan to catch an Atalanta football match, an Italian professional football club of which he is part owner. But before his flight, he stopped to talk biotech at the Bio-IT World Venture, Innovation & Partnering Conference held in conjunction with the Bio-IT World Conference & Expo.

Arena Bioworks is Pagliuca’s new investment venture, a biomedical research institution focused on uncovering the mechanisms of human disease to identify opportunities for therapeutic intervention. Pagliuca, with Stuart Schreiber and Tom Cahill, co-founded the effort. Founding investors include Pagliuca, Michael Dell, Michael Chambers, Jim Breyer, and Elisabeth DeLuca. The core scientific team includes Stuart Schreiber and Keith Joung, with more to be announced....

Today's Sponsors

Today's Sponsor